PepGen (PEPG) Operating Expenses (2021 - 2026)
PepGen (PEPG) reported Operating Expenses of $18.9 million for Q1 2026, down 39.52% on a YoY basis from $31.3 million in Q1 2025, and down 3.87% sequentially from $19.7 million in Q4 2025.
PepGen (PEPG) Operating Expenses (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Operating Expenses data on file, last reported at $18.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 39.52% year-over-year to $18.9 million; the trailing twelve-month figure through Mar 2026 stood at $81.2 million (down 25.65% YoY), and the FY2025 full-year result was $93.6 million, down 4.22% from the prior year.
- Operating Expenses retreated to $18.9 million in Q1 2026, from $19.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $31.3 million in Q1 2025 to a low of $13.9 million in Q1 2022.
- A 5-year average of $21.4 million and a median of $19.8 million in 2024 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 239.77% in 2022 and tumbled 39.52% in 2026, its largest moves.
- Tracing PEPG's Operating Expenses over 5 years: stood at $17.2 million in 2022, then increased by 20.9% to $20.8 million in 2023, then climbed by 16.98% to $24.3 million in 2024, then slipped by 19.06% to $19.7 million in 2025, then fell by 3.87% to $18.9 million in 2026.
- Business Quant data shows PEPG's Operating Expenses at $18.9 million in Q1 2026, $19.7 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 18.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.94 Mn |
| Dec 31, 2025 | 19.71 Mn |
| Sep 30, 2025 | 18.65 Mn |
| Jun 30, 2025 | 23.93 Mn |
| Mar 31, 2025 | 31.32 Mn |
| Dec 31, 2024 | 24.35 Mn |
| Sep 30, 2024 | 23.17 Mn |
| Jun 30, 2024 | 30.43 Mn |
| Mar 31, 2024 | 19.80 Mn |
| Dec 31, 2023 | 20.81 Mn |
| Sep 30, 2023 | 24.78 Mn |
| Jun 30, 2023 | 21.14 Mn |
| Mar 31, 2023 | 18.03 Mn |
| Dec 31, 2022 | 17.21 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | 17.64 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 7.21 Mn |
| Sep 30, 2021 | 8.08 Mn |
| Jun 30, 2021 | 5.19 Mn |